Stocks tumble as several corporate giants report disappointing earnings for the third quarter.
This bump might indicate that things are worse than business as usual after all.
GlaxoSmithKline is downgraded to 'underperform,' while AstraZeneca is upgraded to 'neutral.'
Things that would make me want to raise some cash and hit the beach.
Stocks are lower at midday and the sluggish trading environment persists as investors remain on the sidelines ahead of Bernanke speech.
Dow sheds 125 points to below 13,000. Weak economic data out of Japan, South Korea and Europe put the focus back on international issues. US retailers report generally better-than-expected sales, while jobless claims remain flat.
Advances in biotech research should alleviate concerns about the widespread use of genetically modified seeds.
VIDEO ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
Tying the knot doesn't mean your credit will follow suit. Take a look at these common credit myths about marriage.
In a tax case, a US judge ruled that the agency's published guidelines don't hold up in court.
MUST-SEE ON MSN
- Video: Easy DIY smoked meats at home
A charcuterie master shares his process for cold-smoking meat at home.
- Jetpacks about to go mainstream
- Weird things covered by home insurance
- Bing: 70 percent of adults report 'digital eye strain'